These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33032207)

  • 41. A multiparametric [
    Leithner D; Horvat JV; Bernard-Davila B; Helbich TH; Ochoa-Albiztegui RE; Martinez DF; Zhang M; Thakur SB; Wengert GJ; Staudenherz A; Jochelson MS; Morris EA; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1878-1888. PubMed ID: 31197455
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Linder G; Korsavidou-Hult N; Bjerner T; Ahlström H; Hedberg J
    Clin Radiol; 2019 Sep; 74(9):718-725. PubMed ID: 31221468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of integrated
    Zeng Y; Leng X; Liao H; Jiang G; Chen P
    Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preliminary comparison of diffusion-weighted MRI and PET/CT in predicting histological type and malignancy of lung cancer.
    Liu LP; Zhang XX; Cui LB; Li J; Yang JL; Yang HN; Zhang Y; Zhou Y; Tang X; Qi S; Fang Y; Zhang J; Yin H
    Clin Respir J; 2017 Mar; 11(2):151-158. PubMed ID: 25918835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
    Afaq A; Fraioli F; Sidhu H; Wan S; Punwani S; Chen SH; Akin O; Linch D; Ardeshna K; Lambert J; Miles K; Groves A; Kayani I
    Clin Nucl Med; 2017 Jan; 42(1):e1-e7. PubMed ID: 27607161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diabetic foot: initial experience with 18F-FDG PET/CT.
    Keidar Z; Militianu D; Melamed E; Bar-Shalom R; Israel O
    J Nucl Med; 2005 Mar; 46(3):444-9. PubMed ID: 15750157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
    Dalah E; Moraru I; Paulson E; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.
    Hectors SJ; Wagner M; Besa C; Huang W; Taouli B
    Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
    Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma.
    Malla SR; Bhalla AS; Manchanda S; Kandasamy D; Kumar R; Agarwal S; Shamim SA; Kakkar A
    Head Neck; 2021 Sep; 43(9):2611-2622. PubMed ID: 33938085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In the evaluation of patients with skull base osteomyelitis, does 18F-FDG PET CT have a role?
    Kulkarni SC; Padma S; Shanmuga Sundaram P
    Nucl Med Commun; 2020 Jun; 41(6):550-559. PubMed ID: 32282638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positron emission computed tomography and magnetic resonance imaging features of sinonasal small round blue cell tumors.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Neuroradiol J; 2020 Feb; 33(1):48-56. PubMed ID: 31460836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Sugimura K
    AJR Am J Roentgenol; 2012 Jan; 198(1):75-82. PubMed ID: 22194481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiparametric evaluation of breast lesions using PET-MRI: initial results and future perspectives.
    Bitencourt AGV; Lima ENP; Chojniak R; Marques EF; Souza JA; Andrade WP; Guimarães MD
    Medicine (Baltimore); 2014 Nov; 93(22):e115. PubMed ID: 25396329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.